Leadership, Planning and Evaluation

NIH RePORTER · NIH · P30 · $320,415 · view on reporter.nih.gov ↗

Abstract

LEADERSHIP, PLANNING & EVALUATION PROJECT SUMMARY/ABSTRACT The Chao Family Comprehensive Cancer Center (CFCCC) has established leadership, planning, and evaluation processes that have significant impact on the CFCCC's development, growth, and ability to capitalize on strategic opportunities. The CFCCC performs regular needs assessments and evaluations that are vitally important to strengthen its basic, translational, clinical, and population sciences research, training and education, and outreach efforts, all of which serve the needs of the CFCCC Catchment Area of Orange County. The Associate Director's Committee, Program Leaders and Shared Resources Committee, and the Senior Leadership Council are internal groups that serve as decision-making bodies for the CFCCC. The External Advisory Board (EAB), Internal Advisory Board (IAB), and Community Equity Board (CEB) provide critical feedback and advice to aid the CFCCC in planning and evaluation activities, with the CEB bringing perspective from the community to the CFCCC's efforts. Through these groups, the CFCCC develops coordinated plans, evaluates progress, addresses challenges, identifies opportunities, and maximizes potential impact. Evaluation is a priority for the CFCCC and is used to ensure that resources and efforts are aligned with CFCCC priorities and strategic planning. Based on input from advisory boards the CFCCC has strategically reviewed Cancer Center membership, and evaluated and improved CFCCC Programs and Shared Resources. On an ongoing basis, and re-evaluated every five years, the CFCCC engages in a detailed process of strategic planning. Most recently, the 2020-2025 Strategic Plan was finalized and forward action on individual tactics has progressed. Implementation of the 2020-2025 CFCCC Strategic Plan is integrally woven into the overall planning and evaluation processes of the Cancer Center. The Specific Aims of Leadership, Planning & Evaluation are to facilitate CFCCC growth with a transdisciplinary leadership team to guide and encourage cancer research collaborations and foster research discovery, proactively establish CFCCC priorities and implement goals, strategies, and tactics, and ensure progress with continuous assessment and thorough evaluation to match resources toward established goals.

Key facts

NIH application ID
10579967
Project number
5P30CA062203-25
Recipient
UNIVERSITY OF CALIFORNIA-IRVINE
Principal Investigator
RICHARD A. VAN ETTEN
Activity code
P30
Funding institute
NIH
Fiscal year
2023
Award amount
$320,415
Award type
5
Project period
1997-09-11 → 2027-01-31